Dysfunctional factor VII variant (FVII tondabayashi) with R79Q: Determination of mutated site with monoclonal anti-human factor VII antibody (B101/B1)

Clinical Chemistry

Volumn 44, Issue 9, 1998, Pages 1993-1995

  Takamiya, Osamu ^a   Takeuchi, Shigeru ^b  

^a SHINSHU UNIVERSITY   (Japan)

^b Saiseikai Tondabayashi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ANTIBODY DETECTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; FEMALE; GENE MUTATION; HUMAN; SCHOOL CHILD;

EID: 0031721547     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.9.1993     Document Type: Article

References (21)

1. Roberts HR, Zeitler KD. Factor VII: serum prothrombin conversion accelerator (SPCA), stable factor, proconvertin, auto-prothrombin I. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Haemorrhagic disorders. Section B. Prothrombin activation, thrombin and fibrinogen. Hemostasis and thrombosis. Philadelphia, PA: Lippincott, 1982:134-7.
2. Mariani G, Mazzucconi MG, Hemans J, Ciavarella N, Faiella A, Hassan HJ, et al. Factor VII deficiency: immunological characterization of genetic variants and detection of carriers. Br J Haematol 1981;48:7-14.
3. Triplett DA, Brandt JT, Batard MA, Dixon JS, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985;66:1284-7.
4. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1987;91:387-95.
5. Girolami A, Catarozzi G, Dal Bo Zanon R, Cella G, Joffanin F. Factor VII Padua 2. Another factor VII abnormality with defective ox brain thromboplastin activation and complex hereditary pattern. Blood 1989;54:46-53.
6. Girolami A, Falezza G, Patrass G, Stemico M, Vettore L. Factor VII Verona coagulation disorder: double heterozygosis with abnormal factor VII and heterozygous factor VII deficiency. Blood 1987;50:603-10.
7. Takamiya O, Abe S, Yoshioka A, Nakajima K, McVey JH, Tuddenham EGD. Factor VII Shinjo: a dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79. Haemostasis 1995;25:89-97.
8. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta 1993;1172:301-5.
9. Chaing SH, High KA. Severe FVII deficiency associated with 2 missense mutations in the factor-VII gene. Thromb Haemost 1991;65:1262.
10. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EGD. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a Verona coagulation disorder: double heterozygosis with abnormal factor VII and clinically unaffected male. Blood 1991;78:132-40.
11. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304→Trp). J Biol Chem 1994;269:7355-63.
12. Takamiya O. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three dimensional structures near Arg at position 79 in the first EGF-like domain. Thromb Haemost 1998;79:104-9.
13. Takamiya O, Kinoshita S, Yoshioka K. Electroimmunoassay of factor VII antigen. Thromb Res 1986;42:847-53.
14. Takamiya O, Yoshioka A. Binding ability of factor VII in plasma from warfarin-treated individuals to tissue factor. Thromb Res 1996;81:657-63.
15. Takamiya O, Kemball-Cook G, Martin DMA, Cooper DN, von Feiten A, Meile E, et al. Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis of coagulation variants of coagulation factor VII. Hum Mol Genet 1993;2:1355-9.
16. Fair DS, Revak DJ, Hubbard JG, Girolami A. Isolation and characterization of the factor VII Friuli variant. Blood 1989;73:2108-16.
17. Mimuro J, Muramatsu S, Kaneko M, Yoshitake S, Iijima K, Nakamura K, et al. An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG→GGG). Deteriorated calcium-dependent conformation of the gamma-carboxyglutamic acid domain relevant to a thrombotic tendency. Int J Hematol 1993;57:9-14.
18. Clarke BJ, Ofosu FA, Sridhara S, Bona RD, Rickles FR, Blajchman MA. The 1st epidermal growth-factor domain of human coagulation factor-VII is essential for binding with tissue factor. FEBS Lett 1992;298:206-10.
19. Chang JY, Stafford DW, Straight DL. The roles of factor VII's structural domains in tissue factor binding. Biochemistry 1995;34:12227-32.
20. O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DMA, Johnson DJD, Byfield PGH, et al. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant factor VII molecule (FVII-R79Q). Biochemistry 1994;33:14162-9.
21. Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996;380:41-6.